Prevention of thromboembolic complications in the rehabilitation center: Diagnostic and risk factor stratification tools

American Journal of Physical Medicine and Rehabilitation

Volumn 79, Issue 5 SUPPL., 2000, Pages

  Muntz, James E ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Deep Vein Thrombosis; Enoxaparin; Low Molecular Weight Heparin; Physical Medicine and Rehabilitation Deep Vein Thrombosis; Prophylaxis; Pulmonary Embolism; Risk Stratification in Deep Vein Thrombosis; Spinal Cord Patients and Deep Vein Thrombosis

Indexed keywords

ALGORITHM; ARTICLE; CLINICAL PATHWAY; HUMAN; METHODOLOGY; PHYSICAL MEDICINE; PRACTICE GUIDELINE; REHABILITATION; REHABILITATION CENTER; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM;

ALGORITHMS; CRITICAL PATHWAYS; HUMANS; PHYSICAL MEDICINE; PRACTICE GUIDELINES; REHABILITATION; REHABILITATION CENTERS; RISK ASSESSMENT; RISK FACTORS; THROMBOEMBOLISM;

BLOOD VESSELS; DISEASES; HEALTH RISKS; ORGANIC ACIDS; POLYSACCHARIDES; PREVENTION;

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHYSICAL MEDICINE; PROPHYLAXIS; PULMONARY EMBOLISM; THROMBOEMBOLIC COMPLICATION;

PATIENT REHABILITATION;

EID: 0034269278     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Thromboembolic Risk Factors (THRIFT) Consensus Group: Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992;305:567-74
2. Turpie AGG: Management of deep vein thrombosis: Prevention and treatment. Pharmacol Ther 1995;June:7S-15S
3. Leclerc JR, Geerts WH, Desjardins L, et al: Prevention of venous thromboembolism after knee arthroplasty: a randomized, double-blind trial comparing enoxaparin with warfarin. Adv Intern Med 1996;124:619-26
4. Clagett GP, Anderson FA, Geerts W, et al: Prevention of venous thromboembolism. Fifth American College of Chest Physicians Consensus Conference on Antithrombotic Therapy. Chest 1998; 114(suppl):531S-60S
5. Haake DA, Berkman SA: Venous thromboembolic disease after hip surgery. Clin Orthop 1989;242:212-231
6. Inman WNW, Vessey MP, Westerholm B, et al: Thromboembolic disease and the steroidal content of oral contraceptives: a report to the Committee of Safety of Drugs. BMJ 1970;2:203
7. Vessey MP: Female hormones and vascular disease: epidemiologic overview. Br J Fam Plann 1980;6:1
8. Levine MN: Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thromb Haemost 1997; 78:133-6
9. Levine MN: Treatment of thrombotic disorders in cancer patients. Haemostasis 1997;27(suppl 1):38-43
10. Colwell CW, Spiro TE, Trowbridge AA, et al: Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. J Bone Joint Surg Am 1994;76:3-14
11. Colwell CW, Collis DK, Paulson R, et al: Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. J Bone Joint Surg Am 1999;81:932-40